In a study by Hu et al. [35] a reduction in diastolic BP of −0.898 mmHg, p < 0.001, was reported in patients with T2DM treated with GLP-1 RAs, consistent with our study results, where we found a reduction at V6M as compared to V0M and V12M as compared to V0M (Table 3, Table 4 and Table 5). This evidence concerns the gene GLP1R and type 2 diabetes mellitus.